PlaqueTec Closes $5 Million Financing
PlaqueTec has raised $5 million in an oversubscribed financing round, funded entirely by existing investors. The investment will aid in the development of BioCarta, a proprietary cardiovascular data lake that collects unique intracoronary proteomic and clinical data.
CAMBRIDGE, England–(BUSINESS WIRE)–PlaqueTec, a medtech company pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease (CVD), today announced it has raised $5 million. The oversubscribed financing round was funded entirely by the Company’s existing investor base. The investment will support the continued build-out of PlaqueTec’s proprietary cardiovascular data lake, BioCarta, a growing repository of unique intracoronary proteomic and clinical data. B